Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 125 active Myeloproliferative Neoplasms trials
Quantitative MRI for Myelofibrosis
Study Type: Observational
Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
Study Type: Interventional Phase 2
A Study of Oral TP-3654 in Patients With Myelofibrosis
Study Type: Interventional Phase 1
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Study Type: Interventional Phase 2
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Study Type: Interventional Phase 1
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
Study Type: Interventional Phase 1
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
Study Type: Interventional Phase 2
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Study Type: Interventional Phase 2
There are 125 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now